Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site

Aclarion logo with a teal-blue intertwined mountain-like symbol next to a divider, followed by The University of Arizona and College of Medicine Phoenix logos, indicating a partnership.

PR Audio: BROOMFIELD, Colo., August 20, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the […]

Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan’s MR Spectroscopy (MRS) Scan Process

Logo featuring an abstract green and blue mountain over the word Aclarion in bold black letters.

BROOMFIELD, Colo., August 12, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced that the United States […]

Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology

Aclarion logo on the left and Goodman Campbell Brain and Spine logo on the right, divided by a vertical bar.

PR Audio: BROOMFIELD, Colo., August 04, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced that its […]

Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026

Logo featuring an abstract green and blue mountain over the word Aclarion in bold black letters.

PR Audio: Broomfield, CO, July 29, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the publication […]

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice

Aclarion logo featuring green-to-blue gradient mountain peaks above the bold, black word ACLARION.

PR Audio: BROOMFIELD, Colo., July 21, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the […]

Aclarion Announces Texas Spine Care Center as New CLARITY Site

Left: Aclarion logo with green–blue intertwined 'A' symbol; right: Texas Spine Care Center logo, split by a vertical divider, suggesting a partnership.

PR Audio: BROOMFIELD, Colo., July 07, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced Texas […]

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Broomfield, CO, June 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its Nociscan® platform to help physicians identify the location of chronic low back pain and support improved treatment […]

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Split logo banner: left panel shows Aclarion wordmark with a gradient blue‑green mountain-like A symbol; right panel shows PRIA with 'Accelerating Healthcare Innovation' slogan, separated by a vertical divider.

Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion’s AI-driven platform for chronic low back pain. Program aims to follow successful reimbursement wins in the UK that are translating into sustained scan volume growth in step with reduced market access barriers PR Audio: Broomfield, CO, June 09, 2026 – PRISM MediaWire (Press Release Service […]

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

Aclarion logo: green-to-blue mountain and wave icon above the word ACLARION in bold black lettering.

PR Audio: BROOMFIELD, Colo., June 8, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today issued […]

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion logo: green-to-blue mountain and wave icon above the word ACLARION in bold black lettering.

PR Audio: BROOMFIELD, Colo., June 8, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced […]